Full text is available at the source.
Lactiplantibacillus plantarumCCFM1019 attenuate polycystic ovary syndrome through butyrate dependent gut–brain mechanism
Lactiplantibacillus plantarum CCFM1019 may reduce polycystic ovary syndrome through a gut-brain process involving butyrate
AI simplified
Abstract
CCFM1019 reduced PCOS symptoms in a letrozole-induced model by restoring hormone levels and altering gut microbiota.
- CCFM1019 alleviated ovarian pathological changes in a rat model of PCOS.
- Restoration of testosterone and luteinising hormone levels was observed with CCFM1019 treatment.
- Metabolic disorders induced by letrozole were not significantly reversed by CCFM1019.
- Alterations in gut microbial diversity and increases in short-chain fatty acid producers were noted after CCFM1019 intervention.
- Rats treated with CCFM1019 showed higher levels of butyrate and polypeptide YY compared to letrozole-treated rats.
- A potential gut-brain mechanism involving butyrate regulation may contribute to the protective effects of CCFM1019.
AI simplified